These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11235863)

  • 41. Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy.
    Nafziger AN; Bertino JS; Goss-Bley AI; Kashuba AD
    J Clin Psychiatry; 1999 Mar; 60(3):187-90. PubMed ID: 10192595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxicity with selective serotonin reuptake inhibitors.
    Solomons K; Gooch S; Wong A
    Am J Psychiatry; 2005 Jun; 162(6):1225. PubMed ID: 15930079
    [No Abstract]   [Full Text] [Related]  

  • 43. Fluvoxamine: safety profile in extensive post-marketing surveillance.
    Buchberger R; Wagner W
    Pharmacopsychiatry; 2002 May; 35(3):101-8. PubMed ID: 12107854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.
    Black K; Shea C; Dursun S; Kutcher S
    J Psychiatry Neurosci; 2000 May; 25(3):255-61. PubMed ID: 10863885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Withdrawal reactions associated with venlafaxine.
    Parker G; Blennerhassett J
    Aust N Z J Psychiatry; 1998 Apr; 32(2):291-4. PubMed ID: 9588310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of amyotrophic lateral sclerosis with SIADH and throbbing headache induced by selective serotonin reuptake inhibitor].
    Nakazato Y; Takei K; Yamazato M; Tamura N; Shimazu K
    Rinsho Shinkeigaku; 2002 Jan; 42(1):48-50. PubMed ID: 12355854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.
    Zanardi R; Serretti A; Rossini D; Franchini L; Cusin C; Lattuada E; Dotoli D; Smeraldi E
    Biol Psychiatry; 2001 Sep; 50(5):323-30. PubMed ID: 11543734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients.
    Strik JJ; Honig A; Lousberg R; Cheriex EC; Van Praag HM
    Int Clin Psychopharmacol; 1998 Nov; 13(6):263-7. PubMed ID: 9861576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
    Ottevanger EA
    Encephale; 1995; 21(4):317-21. PubMed ID: 7588171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Re: Depression, stroke diagnosis, and SSRI discontinuation syndrome.
    Haddad PM; Dursun SM
    Can J Psychiatry; 2004 May; 49(5):343-4; author reply 345-6. PubMed ID: 15198473
    [No Abstract]   [Full Text] [Related]  

  • 51. Serotonin syndrome induced by fluvoxamine and mirtazapine.
    Demers JC; Malone M
    Ann Pharmacother; 2001 Oct; 35(10):1217-20. PubMed ID: 11675850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
    Fabre L; Birkhimer LJ; Zaborny BA; Wong LF; Kapik BM
    Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine].
    Rüth U; Mayer-Rosa J; Schlamp D; Freisleder FJ
    Z Kinder Jugendpsychiatr Psychother; 2000 May; 28(2):105-8. PubMed ID: 10863766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Digital infarction in a patient with Raynaud's phenomenon associated with treatment with a specific serotonin reuptake inhibitor. A case report.
    Bell C; Coupland N; Creamer P
    Angiology; 1996 Sep; 47(9):901-3. PubMed ID: 8810657
    [No Abstract]   [Full Text] [Related]  

  • 55. Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial.
    Shalbafan M; Malekpour F; Tadayon Najafabadi B; Ghamari K; Dastgheib SA; Mowla A; Shirazi E; Eftekhar Ardebili M; Ghazizadeh-Hashemi M; Akhondzadeh S
    J Psychopharmacol; 2019 Nov; 33(11):1407-1414. PubMed ID: 31575326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved outcome in fluvoxamine-treated patients with SSRI-induced sexual dysfunction.
    Banov MD
    J Clin Psychiatry; 1999 Dec; 60(12):866-8. PubMed ID: 10665636
    [No Abstract]   [Full Text] [Related]  

  • 57. Serotonin syndrome induced by fluvoxamine and oxycodone.
    Karunatilake H; Buckley NA
    Ann Pharmacother; 2006 Jan; 40(1):155-7. PubMed ID: 16368927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The onset and time course of response of negative symptoms to add-on fluvoxamine treatment.
    Silver H; Nassar A; Aharon N; Kaplan A
    Int Clin Psychopharmacol; 2003 Mar; 18(2):87-92. PubMed ID: 12598819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors.
    Kindler S; Dannon PN; Iancu I; Sasson Y; Zohar J
    Clin Neuropharmacol; 1997 Apr; 20(2):126-9. PubMed ID: 9099464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case of rapid bilateral cataract development in teenager using selective serotonin reuptake inhibitors.
    Kisilevsky E; Margolin EA
    Can J Ophthalmol; 2014 Oct; 49(5):e114-5. PubMed ID: 25284112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.